Amrize (NYSE:AMRZ) Earns Overweight Rating from Analysts at Stephens

Stephens initiated coverage on shares of Amrize (NYSE:AMRZFree Report) in a research report sent to investors on Friday morning, Marketbeat.com reports. The brokerage issued an overweight rating and a $60.00 target price on the stock.

A number of other equities analysts have also recently weighed in on the company. Zacks Research upgraded Amrize from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Kepler Capital Markets upgraded shares of Amrize to a “strong-buy” rating in a research note on Tuesday, October 21st. Wall Street Zen raised shares of Amrize to a “hold” rating in a research note on Saturday, October 25th. Barclays assumed coverage on shares of Amrize in a research report on Tuesday, October 7th. They issued an “equal weight” rating for the company. Finally, JPMorgan Chase & Co. lifted their target price on Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Amrize currently has a consensus rating of “Moderate Buy” and an average target price of $58.88.

Get Our Latest Analysis on Amrize

Amrize Stock Down 1.6%

Shares of AMRZ stock opened at $48.94 on Friday. The firm has a market capitalization of $27.07 billion and a PE ratio of 26.60. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $56.29. The firm’s 50 day simple moving average is $50.16.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). Amrize’s revenue for the quarter was up 6.6% on a year-over-year basis.

Insider Activity

In other news, CTO Roald Brouwer purchased 4,000 shares of the firm’s stock in a transaction that occurred on Friday, October 31st. The stock was acquired at an average cost of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the purchase, the chief technology officer owned 9,000 shares of the company’s stock, valued at approximately $465,930. This trade represents a 80.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jan Philipp Jenisch acquired 55,000 shares of the stock in a transaction that occurred on Thursday, October 30th. The stock was purchased at an average cost of $52.64 per share, with a total value of $2,895,200.00. Following the completion of the acquisition, the chief executive officer owned 1,505,000 shares of the company’s stock, valued at $79,223,200. The trade was a 3.79% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have purchased 65,500 shares of company stock worth $3,433,595.

Institutional Investors Weigh In On Amrize

Institutional investors have recently modified their holdings of the business. Vanguard Group Inc. acquired a new stake in shares of Amrize during the 2nd quarter worth approximately $1,065,029,000. Norges Bank bought a new position in shares of Amrize in the second quarter valued at $670,915,000. Dodge & Cox acquired a new position in shares of Amrize in the 2nd quarter valued at $622,085,000. JPMorgan Chase & Co. purchased a new position in shares of Amrize in the second quarter worth approximately $220,404,000. Finally, Wellington Management Group LLP boosted its position in Amrize by 48.8% during the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock worth $561,018,000 after acquiring an additional 3,809,133 shares during the period.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.